Speaker Abstract: Breakout Session A
Three Perspectives on Confidentiality, Conflict of Interest, and Privacy Issues Surrounding the Advancing Science of Gene Therapy

As a clinical investigator directly involved in gene therapy clinical trials (thus far numbering 16, including the first trial in September 1990), the speaker will respond to the presentations of Dr. Noguchi of the FDA and Ms. Golodner of the National Consumers League by explaining how investigators deal with the multitude of issues raised by gene therapy trials.